Abstract C031: A randomized Phase 1b study of IGM-8444 in combination with FOLFIRI + bevacizumab compared to FOLFIRI + bevacizumab alone in second line metastatic colorectal cancer by Ulahannan, Susanna, Pelster, Meredith, LoRusso, Patricia, Falchook, Gerald, Wang, Judy, Barve, Minal, Grewal, Jaspreet, Chow, Warren, Henry, Jason, Cecchini, Michael, Subbiah, Vivek, Leabman, Maya, Hernandez, Genevive, Li, Yao, Sinclair, Angus, Wang, Beatrice, Kotturi, Maya, Humke, Eric, Ahern, Sean, Ennis, Leslie, Caruano, Melaine, Agrawal, Sapeck

Get full text